cbdMD, Inc. YCBD
Package Goods/Cosmetics · IPO 2017 · data as of November 13, 2026
cbdMD, Inc. (YCBD) is a consumer discretionary company listed in the US with a market value of about $5M. In the twelve months to June 30, 2026 it had revenue of $21M and net income of -$3M, a net margin of -13.8%.
Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of -14% a year, a 5-year average ROIC of -120%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 90% below the current price.
About cbdMD
cbdMD is listed in the US and classified in package goods/cosmetics, IPO year 2017. Revenue went from $2M in 2016 to $19M in 2025, growth of about 28.3% a year. It was profitable in 2 of the last 10 years in our data. Its share count rose by 2324% over three years (dilution for shareholders).
Score: 0.6 / 5
Checks passed
- Profit margin improving
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21M | $19M | $19M | $24M | $35M | $44M | $42M | $24M | $459091 | $4M | $2M |
| Net income | -$3M | -$2M | -$4M | -$23M | -$70M | -$23M | $13M | -$51M | $62834 | -$1M | -$4M |
| Free cash flow | -$2M | -$2M | -$542807 | -$5M | -$16M | -$14M | -$12M | -$17M | -$6M | -$2M | -$3M |
| EPS (diluted) | $0.24 | $-1.09 | $-14.29 | $-106.56 | $-446.40 | $-169.20 | $100.80 | $0.00 | $0.00 | $-136.80 | $-406.80 |
| Net margin | -13.8% | -10.6% | -19.0% | -95.0% | -198.0% | -52.6% | 30.1% | -217.1% | 13.7% | -31.0% | -191.8% |
| ROIC | — | -27.0% | -160.8% | -173.0% | -220.3% | -17.3% | -17.9% | -37.4% | -12.8% | -25.5% | -264.6% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is cbdMD stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 90% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does cbdMD pay a dividend?
Not currently.
Is cbdMD a good stock to buy?
We do not give buy or sell advice. cbdMD scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.